With the increase in high-cost oncologic medications being utilized in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the departmental budget as well as ensuring optimal patient outcomes. Hospitals may vary widely in the resources dedicated to performing these assessments. Please join us in this series as we discuss strategies for managing high-cost oncologic medications with pharmacy leaders from two large academic medical centers. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.